Kyle LaHucik has been hired by Endpoints News as an associate editor covering the money, people, science and startups behind the drug development industry.
He was previously a staff writer at Fierce Biotech.
LaHucik previously reported on venture capital- and private equity-backed tech, digital health and SaaS companies for Mergermarket. He has also covered the rise of SPACs, a burgeoning teletherapy space and other COVID-accelerated trends within tech.
Through various internships, LaHucik has previously reported on the Big Three automakers for Bloomberg’s Detroit bureau, profiled the University of Missouri’s first Nobel Laureate for the Columbia Missourian, covered privacy regulation for Bloomberg Industry Group, wrote Missouri Business Alert’s daily newsletter and assisted reporters in MLex’s Brussels newsroom.
He graduated from the University of Missouri in May 2019 with a bachelor’s degree in journalism and minors in English creative writing and architectural studies.
PCWorld executive editor Gordon Mah Ung, a tireless journalist we once described as a founding father…
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…